Fibrosis lacks treatments and methods of reversal: Study pinpoints a promising target for drug therapy
Medical science has long been on the hunt for a deeper understanding of the devastating scarring of the body's organs known ...
Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of ...
healthcare-in-europe.com3d
Fibrosis a prognostic biomarker for HER2-negative breast cancer
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
Medindia4d
FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER
Fast Track Designation is available to drugs that may provide an advantage over current therapies in the treatment of serious conditions. It is designed to speed the development o ...
Science Daily4d
COPD News
According to a ... Researchers Identify Protein Connected to Aging and Idiopathic Pulmonary Fibrosis July 25, 2022 — Idiopathic pulmonary fibrosis (IPF) is an aging-associated disease caused by ...
Study confirms fibrosis as a prognostic indicator in the most common breast cancer
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
Outsourcing-pharma4d
Insilico Medicine claims phase 2 win for AI-designed drug
The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...
The American Journal of Managed Care4d
FIBRONEER-IPF Trial of Nerandomilast Meets Primary End Point
The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...
Insilico Medicine reports preliminary data from Phase IIa IPF treatment trial
Insilico Medicine has announced positive preliminary results from its Phase IIa clinical trial of ISM001-055, a small ...
cmft.nhs.uk4d
Low dose morphine shows promise as effective treatment for chronic cough in people with idiopathic pulmonary fibrosis
Low dose morphine has the potential to treat chronic cough in people with idiopathic pulmonary fibrosis (IPF), according to new research from two National Institute for Health and Care ...